This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Pfizer Corporation. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: Allen Thomas Horhota: Innovator in Therapeutic Nanoparticles
Introduction
Allen Thomas Horhota is a notable inventor based in Westford, MA (US). He has made significant contributions to the field of therapeutic nanoparticles, holding 2 patents that focus on innovative methods and applications in this area.
Latest Patents
Horhota's latest patents include "Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same." This patent relates to nanoparticles that incorporate an endo-lysosomal escape agent, a nucleic acid, and a polymer. The disclosure also covers methods for making and utilizing these nanoparticles. Another significant patent is "Therapeutic nanoparticles having EGFR ligands and methods of making and using same." This invention features a therapeutic nanoparticle that includes a biocompatible polymer and a polymer-EGFR ligand conjugate, where the EGFR ligand is covalently bound to the polymer, along with a therapeutic agent.
Career Highlights
Horhota is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work focuses on the development of advanced therapeutic solutions that leverage the potential of nanoparticles.
Collaborations
Throughout his career, Horhota has collaborated with esteemed colleagues, including Stephen E. Zale and Kevin McDonnell. These partnerships have contributed to the advancement of his research and innovations in the field.
Conclusion
Allen Thomas Horhota is a prominent figure in the realm of therapeutic nanoparticles, with a strong portfolio of patents that reflect his innovative spirit and dedication to advancing medical technology. His contributions continue to shape the future of therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
